Europe’s vaccine rollout needs AstraZeneca — but public confidence is dented
The European Union aims to vaccinate 70% of its adult population by September. But anxiety over a possible link between the Oxford-AstraZeneca vaccine and reported blood clot cases may put that target in jeopardy. Europe’s vaccine rollout has already been slower than expected. Meanwhile, the continent is confronting a third wave of the pandemic, fueled
Continue Reading